Clinical Trial Update: Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel with or without carboplatin in women with metastatic breast cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Theradex | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN